![](/img/cover-not-exists.png)
The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis
Zabotti, Alen, Goletti, Delia, Lubrano, Ennio, Cantini, FabrizioVolume:
19
Journal:
Expert Opinion on Drug Safety
DOI:
10.1080/14740338.2020.1703946
Date:
January, 2020
File:
PDF, 1.76 MB
2020